Journal article

First-line therapy with temozolomide induces regression of primary CNS lymphoma.

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Herrlinger, U., Küker, W., Platten, M., Dichgans, J., & Weller, M. (2002). First-line therapy with temozolomide induces regression of primary CNS lymphoma. Neurology, 58(10), 1573–1574.

MLA Style

Herrlinger, U, et al. “First-Line Therapy with Temozolomide Induces Regression of Primary CNS Lymphoma.” Neurology, vol. 58, no. 10, 2002, pp. 1573–74.

Chicago Style

Herrlinger, U, W Küker, M Platten, J Dichgans, and M Weller. 2002. “First-Line Therapy with Temozolomide Induces Regression of Primary CNS Lymphoma.” Neurology 58 (10): 1573–74.
Print

Access Document

Publisher copy:: 10.1212/wnl.58.10.1573

Authors

+ Herrlinger, U More by this author

Role:: Author

+ Küker, W More by this author

Role:: Author

+ Platten, M More by this author

Role:: Author

+ Dichgans, J More by this author

Role:: Author

+ Weller, M More by this author

Role:: Author

Journal:: Neurology More from this journal
Volume:: 58
Issue:: 10
Pages:: 1573-1574
Publication date:: 2002-05-01
DOI:: 10.1212/wnl.58.10.1573
EISSN:: 1526-632X
ISSN:: 0028-3878

Language:: English
Keywords:: Aged

Male

Middle Aged

Lymphoma

Female

Dacarbazine

Central Nervous System Neoplasms

Humans

Antineoplastic Agents, Alkylating
Pubs id:: pubs:241449
UUID:: uuid:065aa108-d3dc-4bbe-87fb-adbf838362f3
Local pid:: pubs:241449
Source identifiers:: 241449
Deposit date:: 2012-12-19
ARK identifier:: ark:/29072/ora_065aa108d3dc4bbe87fbadbf838362f3

Terms of use

Copyright date:: 2002

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP